Global Angioplasty Balloons & Stents Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In January 2023, the FDA granted approval to Philips Image Guided Therapy Corp. for their Stellarex 0.035" OTW Drug-coated Angioplasty Balloon – P160049/S015.

• In November 2022, TriReme Medical LLC, under Genesis MedTech Group, received FDA approval for the Chocolate Touch® Drug-coated Balloon PTA Catheter. This approval applies to treating patients with peripheral artery disease in the superficial femoral artery and the popliteal artery.

The Global Angioplasty Balloons & Stents Market is segmented by product, which includes angioplasty balloons and angioplasty stents. Angioplasty balloons are used in percutaneous coronary intervention (PCI) to open narrowed or blocked blood vessels, primarily in the coronary arteries. These balloons are inflated at the site of the blockage to restore blood flow. Angioplasty stents are small mesh-like devices inserted into arteries to keep them open after balloon angioplasty. They are often made of metal or drug-eluting materials that prevent re-narrowing of the arteries. Drug-eluting stents (DES) release medication to reduce the risk of restenosis, making them highly effective in preventing artery re-blockage. The combination of balloons and stents is crucial for treating coronary artery disease (CAD), which is the leading cause of heart-related ailments globally.

The market is also segmented by indication, including coronary artery disease (CAD), peripheral artery disease (PAD), and renal artery disease (RAD). CAD remains the dominant indication, accounting for the largest share of the market, as angioplasty balloons and stents are primarily used in treating coronary artery blockages. Peripheral artery disease (PAD), which affects the arteries in the limbs, is an emerging segment as more people with diabetes and atherosclerosis are diagnosed with PAD. Renal artery disease (RAD), which affects the arteries leading to the kidneys, is another growing area where angioplasty and stent placement are increasingly used to improve renal blood flow, particularly in patients with hypertension and chronic kidney disease.

The end-users of angioplasty balloons and stents include hospitals, ambulatory surgical centers (ASCs), and specialized clinics. Hospitals are the largest consumers of these products, driven by the high volume of angioplasty and PCI procedures performed for CAD, PAD, and RAD. Ambulatory surgical centers (ASCs) are a growing segment due to the rising number of outpatient procedures and the shift toward less invasive treatments for arterial diseases. Specialized clinics, particularly those focusing on cardiovascular care, also contribute to the market, especially in regions with higher access to specialized treatment. Geographically, the Global Angioplasty Balloons & Stents Market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America holds the largest market share, due to high adoption rates of advanced stent technologies, increasing incidence of cardiovascular diseases, and robust healthcare infrastructure. Europe follows, driven by increasing government initiatives to tackle heart diseases and growing demand for minimally invasive treatments. The Asia-Pacific region is expected to witness the highest growth, propelled by rising healthcare access, an aging population, and a growing prevalence of heart diseases, particularly in countries like China and India.

Global Angioplasty Balloons & Stents Segment Analysis

In this report, the Global Angioplasty Balloons & Stents Market has been segmented by Product, Indication, End-user and Geography.

Global Angioplasty Balloons & Stents Market, Segmentation by Product

The Global Angioplasty Balloons & Stents Market has been segmented by Product into Stents and Balloons.

Stents are a critical component of angioplasty procedures, designed to keep arteries open after balloon angioplasty (which involves inflating a small balloon inside a narrowed artery to widen it). These devices are typically made of metal (such as stainless steel, cobalt-chromium alloy, or platinum-chromium alloy) or sometimes from a biodegradable material that dissolves over time. The primary function of a stent is to provide structural support to the artery walls, preventing them from collapsing after the balloon has been used to widen the artery. Stents come in various designs, including bare-metal stents (BMS) and drug-eluting stents (DES), the latter of which release medications that help prevent the re-narrowing of the artery, known as restenosis. The stents segment of the global market is characterized by ongoing advancements in material science, biocompatibility, and drug delivery technologies, aimed at enhancing the efficacy and safety of these devices in cardiovascular interventions.

Angioplasty balloons are inflatable devices used in conjunction with catheters to open blocked or narrowed blood vessels. These balloons are typically made of materials like nylon, polyethylene, or polyvinyl chloride and come in various sizes and shapes to suit different anatomical requirements. The primary function of angioplasty balloons is to compress the plaque against the artery walls and widen the narrowed vessel to restore blood flow. They are crucial in the initial phase of angioplasty procedures before stents are deployed, and their effectiveness directly impacts procedural outcomes. The market for angioplasty balloons is driven by advancements in balloon materials, designs, and coatings that enhance deliverability, trackability, and inflation characteristics, making them safer and more effective for treating complex coronary and peripheral artery diseases.

Global Angioplasty Balloons & Stents Market, Segmentation by Indication

The Global Angioplasty Balloons & Stents Market has been segmented by Indication into Coronary Artery Diseases and Peripheral Artery Diseases.

Coronary artery diseases (CAD) constitute a substantial portion of the market due to their prevalence and critical nature. CAD occurs when plaque buildup narrows the coronary arteries, restricting blood flow to the heart muscle and potentially leading to serious complications like heart attacks. Angioplasty balloons and stents play a crucial role in managing CAD by restoring blood flow through a minimally invasive procedure. The growing awareness among patients and healthcare providers about the benefits of timely intervention has bolstered the adoption of these devices.

Peripheral artery diseases (PAD) affect arteries outside the heart and brain, typically narrowing the vessels that supply blood to the limbs. PAD can cause pain, reduced mobility, and in severe cases, lead to amputation if left untreated. Angioplasty balloons and stents are vital in treating PAD by opening blocked arteries and improving blood flow to the affected limbs. The rising prevalence of risk factors such as diabetes, smoking, and hypertension contributes to the increasing incidence of PAD globally, thereby driving the demand for these interventional devices.

Global Angioplasty Balloons & Stents Market, Segmentation by End-user

The Global Angioplasty Balloons & Stents Market has been segmented by End-user into Hospitals, Ambulatory Surgical Centers and Cath Labs.

Hospitals constitute a major segment within the angioplasty balloons and stents market. They are primary centers for the diagnosis and treatment of cardiovascular diseases, offering a wide range of procedures including angioplasty. Hospitals are equipped with advanced facilities and skilled medical professionals capable of handling complex cases, which makes them a crucial part of the market. Additionally, the rising number of hospital admissions due to cardiac conditions further supports the demand for angioplasty procedures and associated devices.

Ambulatory surgical centers (ASCs) have gained prominence in recent years as convenient facilities for performing minimally invasive procedures such as angioplasty. ASCs offer several advantages including reduced hospital stays, lower costs, and quicker recovery times for patients. These centers are equipped with specialized equipment and staffed with healthcare professionals trained in interventional cardiology, making them an attractive choice for patients seeking outpatient treatments.

Cath labs, also known as cardiac catheterization laboratories, are specialized facilities dedicated to performing diagnostic and therapeutic procedures for heart conditions. They play a critical role in the angioplasty balloons and stents market by providing a controlled environment for complex cardiovascular interventions. Cath labs are equipped with advanced imaging technologies such as fluoroscopy and angiography systems, enabling precise placement of stents and balloons during procedures.

Global Angioplasty Balloons & Stents Market, Segmentation by Geography

In this report, the Global Angioplasty Balloons & Stents Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Angioplasty Balloons & Stents Market Share (%), by Geographical Region, 2024

North America dominates the global angioplasty balloons and stents market owing to the high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and early adoption of advanced medical technologies. The United States particularly accounts for a significant share due to robust healthcare expenditure and a large patient pool requiring cardiovascular interventions. Moreover, the presence of key market players and ongoing research and development activities contribute to the region's market growth. Regulatory frameworks such as FDA approvals also influence market dynamics, ensuring product safety and efficacy.

Europe represents another substantial market for angioplasty balloons and stents, characterized by a growing geriatric population susceptible to cardiovascular diseases. Countries such as Germany, France, and the United Kingdom are major contributors to market growth, supported by favorable reimbursement policies and increasing healthcare expenditures. The region benefits from well-established healthcare systems that emphasize early diagnosis and intervention, driving demand for advanced cardiovascular treatments. Market players in Europe focus on innovation and strategic collaborations to maintain competitiveness and expand their market presence.

The Asia Pacific region exhibits rapid growth in the angioplasty balloons and stents market, driven by improving healthcare infrastructure, rising disposable incomes, and increasing awareness about cardiovascular diseases. Countries like China, India, and Japan are pivotal to market expansion due to their large population bases and rising incidence of lifestyle-related disorders. Government initiatives aimed at improving healthcare access and affordability further contribute to market growth. However, variability in regulatory frameworks across countries presents challenges for market penetration, necessitating adaptation strategies by global manufacturers.

The Middle East and Africa region show promising growth prospects in the angioplasty balloons and stents market, albeit from a smaller base compared to other regions. Factors such as improving healthcare infrastructure, rising healthcare spending, and a growing prevalence of cardiovascular diseases drive market expansion. Countries like Saudi Arabia, UAE, and South Africa are key markets due to their efforts to enhance healthcare services and infrastructure development. However, challenges such as economic volatility and political instability in some regions may impact market growth trajectory.

Latin America represents a growing market for angioplasty balloons and stents, supported by increasing healthcare investments and rising awareness about cardiovascular diseases. Brazil, Mexico, and Argentina are major contributors to regional market growth due to expanding healthcare coverage and demographic trends favoring cardiovascular interventions. Regulatory harmonization efforts across Latin American countries facilitate market entry for global manufacturers, although economic fluctuations and healthcare access disparities pose challenges.

This report provides an in depth analysis of various factors that impact the dynamics of Global Angioplasty Balloons & Stents Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers

• Technological advancements
• Increasing prevalence of cardiovascular diseases
• Growing demand for minimally invasive procedures

• Rising elderly population: The global market for angioplasty balloons and stents is experiencing significant growth, driven largely by the rising elderly population worldwide. As people age, the incidence of cardiovascular diseases such as coronary artery disease (CAD) and peripheral artery disease (PAD) tends to increase. Angioplasty balloons and stents play a crucial role in the treatment of these conditions by restoring blood flow in narrowed or blocked arteries. With advancements in medical technology and the increasing adoption of minimally invasive procedures, the demand for these devices is expected to rise further.

  Elderly individuals are particularly prone to cardiovascular diseases due to factors such as atherosclerosis, hypertension, and diabetes, which contribute to the narrowing of arteries. Angioplasty procedures involving balloons and stents provide a less invasive alternative to traditional surgical methods, offering quicker recovery times and reduced risks compared to open-heart surgeries. This has made them increasingly popular among elderly patients and healthcare providers alike, driving the expansion of the market.

  Improvements in the design and materials used in angioplasty balloons and stents have enhanced their effectiveness and safety profiles, making them suitable for a broader range of patients, including those with complex medical conditions. As healthcare systems worldwide focus on managing the health needs of aging populations, the angioplasty balloons and stents market is poised to capitalize on these demographic trends. Innovations such as drug-eluting stents, which release medications to prevent re-narrowing of arteries, are also contributing to market growth by improving patient outcomes and reducing the need for repeat procedures.

Restraints

• High cost of devices
• Stringent regulatory requirements
• Limited reimbursement policies

• Complications associated with procedures: The global market for angioplasty balloons and stents has seen significant growth driven by advancements in medical technology and increasing prevalence of cardiovascular diseases worldwide. Angioplasty procedures involving balloons and stents are common interventions used to treat narrowed or blocked blood vessels, typically caused by conditions like coronary artery disease. While these procedures have proven effective in restoring blood flow to the heart and other organs, they are not without complications.

  One of the primary complications associated with angioplasty procedures is restenosis, where the treated blood vessel becomes narrow or blocked again over time. This occurs due to the buildup of scar tissue at the site of the angioplasty, leading to recurrent symptoms and the need for additional interventions. Although drug-eluting stents (DES) have been developed to mitigate restenosis by releasing medication to prevent scar tissue formation, they are not completely free from this risk. Managing restenosis remains a significant challenge in the field, influencing the choice of treatment strategy and device selection.

  Another notable complication is thrombosis, or blood clotting, particularly in the stented segment of the artery. While stents are designed to promote healing and maintain vessel patency, they can also trigger a clotting response in some patients. This risk is higher in the initial months after stent placement and necessitates the use of antiplatelet medications to prevent clot formation. Balancing the risk of thrombosis with the need for antiplatelet therapy poses a clinical dilemma, especially in patients with a high bleeding risk or those requiring long-term antiplatelet therapy.

Opportunities

• Emerging markets in Asia-Pacific
• Development of bioresorbable stents
• Increasing adoption of hybrid procedures

• Personalized medicine approaches: The global market for angioplasty balloons and stents is experiencing significant transformation with the integration of personalized medicine approaches. Traditionally, angioplasty involved the use of generic devices to widen narrowed arteries and implant stents to keep them open. However, advancements in personalized medicine are revolutionizing this field by tailoring treatments to individual patient characteristics. This shift is driven by the recognition that patients respond differently to therapies based on genetic predispositions, lifestyle factors, and disease progression.

  Personalized medicine in angioplasty and stenting involves several key aspects. Firstly, genetic testing is increasingly used to identify biomarkers that can predict how a patient might respond to certain medications or devices. This allows physicians to select the most effective treatment options and optimize patient outcomes. Secondly, innovative technologies such as drug-eluting stents are designed to release medications directly into the arterial walls, targeting specific biological pathways that contribute to restenosis (re-narrowing of arteries). This targeted approach not only improves efficacy but also reduces complications associated with traditional stents.

  The shift towards personalized medicine in angioplasty includes the development of advanced imaging techniques. These technologies enable physicians to visualize plaque buildup and assess arterial function more accurately, guiding precise treatment decisions. Additionally, the integration of big data analytics and artificial intelligence facilitates the interpretation of complex patient data, offering insights into personalized treatment strategies. As the field continues to evolve, collaborations between healthcare providers, researchers, and technology developers are crucial in driving innovation and expanding the capabilities of personalized medicine in angioplasty and stenting. Ultimately, these advancements aim to improve patient outcomes, enhance safety profiles, and reduce healthcare costs associated with cardiovascular diseases globally.

Key players in Global Angioplasty Balloons & Stents Market include:

• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• Terumo Corporation
• B. Braun Melsungen AG
• Biotronik SE & Co. KG
• Cook Medical LLC
• Cardinal Health, Inc
• C. R. Bard, Inc
• Endologix, Inc

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis